The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia von Aumann, Shlomzion, Shaulov, Adir, Haran, Arnon, Gross Even-Zohar, Noa, Vainstein, Vladimir, Nachmias, Boaz

Volltext

Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach von Globerson Levin, Anat, Kronik, Natalie, Shiloach, Tamar, Waks, Tova, Eshhar, Zelig, Vainstein, Vladimir

Volltext

Gene expression changes in male and female rhesus macaque 60 days after irradiation von Majewski, Matthaus, Ostheim, Patrick, Gluzman-Poltorak, Zoya, Vainstein, Vladimir, Basile, Lena, Schuele, Simone, Haimerl, Michael, Stroszczynski, Christian, Port, Matthias, Abend, Michael

Volltext

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis von Avivi, Irit, Perry, Chava, Segman, Yafit, Amit, Odelia, Bar-On, Yaeli, Katz, Ofrat Beyer, Gold, Ronit, Ribakovsky, Elena, Avigdor, Abraham, Vainstein, Vladimir, Goldschmidt, Neta, Ringelstein-Harlev, Shimrit, Horowitz, Netanel A., Gutwein, Odit, Gurion, Ronit, Itchaki, Gilad, Abadi, Uri, Nemets, Anatoly, Sofer, Orit, Vezker, Miri, Tadmor, Tamar, Dally, Najib, Filanovsky, Kalman, Leiba, Merav, Sarid, Nadav, Benyamini, Noam, Luttwak, Efrat, Herishanu, Yair, Ram, Ron

Volltext

Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database von Shukron, Ofir, Vainstein, Vladimir, Kündgen, Andrea, Germing, Ulrich, Agur, Zvia

Volltext

Integrating in vitro sensitivity and dose-response slope is predictive of clinical response to ABL kinase inhibitors in chronic myeloid leukemia von Vainstein, Vladimir, Eide, Christopher A., O'Hare, Thomas, Shukron, Ofir, Druker, Brian J.

Volltext

Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization von Jager, Eva, van der Velden, Vincent H J, te Marvelde, Jeroen G, Walter, Roland B, Agur, Zvia, Vainstein, Vladimir

Volltext

Cytotoxic Chemotherapy-induced Odontalgia: A Differential Diagnosis for Dental Pain von Zadik, Yehuda, DMD, MHA, Vainstein, Vladimir, MD, Heling, Ilana, DMD, Neuman, Tzahi, MD, Drucker, Scott, BSc, Elad, Sharon, DMD, MSc

Volltext

Outcome of Risk- and Response-Adapted Post-Remission Therapy in Patients with NPM1 AML Treated Intensively von Frisch, Avraham, Ganzel, Chezi, Ofran, Yishai, Krayem, Baher, Vainstein, Vladimir, Haran, Arnon, Nachmias, Boaz

Volltext

OPPORTUNISTIC EVALUATION OF BONE MINERAL DENSITY BY PET-CT IN HODGKIN LYMPHOMA PATIENTS von Cohen, Bar, Hiller, Nurith, Szalat, Auryan, Vainstein, Vladimir

Volltext

Lymphadenopathy Associated With the COVID-19 Vaccine von Hiller, Nurith, Goldberg, Shraga Nahum, Cohen-Cymberknoh, Malena, Vainstein, Vladimir, Simanovsky, Natalia

Volltext

Belantamab Mafodotin in Relapse/Refractory AL Amyloidosis- Real-Life Multi-Center Experience von Lebel, Eyal, Vainstein, Vladimir, Milani, Paolo, Palladini, Giovanni, Shragai, Tamir, Lavi, Noa, Magen, Hila, Miri, Assayag, Avivi Mazza, Irit, Gatt, Moshe E

Volltext

Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis von Pick, Marjorie, Vainstein, Vladimir, Goldschmidt, Neta, Lavie, David, Libster, Diana, Gural, Alexander, Grisariu, Sigal, Avni, Batia, Ben Yehuda, Dina, Gatt, Moshe E.

Volltext

Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics von Kronik, Natalie, Kogan, Yuri, Vainstein, Vladimir, Agur, Zvia

Volltext

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib, Pomalidomide and Dexamethasone Combination As Second or Third-Line Treatment for Triple-Class E... von Cohen, Yael C., Shragai, Tamir, Lavi, Noa, Vaxman, Iuliana, Chubar, Evgeni, Gatt, Moshe E, Ganzel, Chezi, Magen, Hila, Luttwak, Efrat, Mittelman, Moshe, Tzoran, Inna, Vainstein, Vladimir, Lowenton-Spier, Noa, Melamed, Natan, Krayzler, Ella, Pereg, Ilana, Avivi Mazza, Irit

Volltext

Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma von Shamriz, Oded, Parnasa, Elchanan, Rubin, Limor, Talmon, Aviv, Ribak, Yaarit, Lebel, Eyal, Vainstein, Vladimir, Aumann, Shlomzion, Saban, Revital, Gatt, Moshe E., Tal, Yuval

Volltext

Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis von Wolach, Ofir, Frisch, Avraham, Shargian, Liat, Yeshurun, Moshe, Apel, Arie, Vainstein, Vladimir, Moshe, Yakir, Shimony, Shai, Amit, Odelia, Bar-On, Yael, Ofran, Yishai, Raanani, Pia, Nachmias, Boaz, Ram, Ron

Volltext

Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia von Kugler, Eitan, Cohen, Inbar, Amitai, Irina, Ram, Ron, Frisch, Avraham, Nachmias, Boaz, Canaani, Jonathan, Moshe, Yakir, Krayem, Baher, Aumann, Shlomzion, Henig, Israel, Vainstein, Vladimir, Shargian, Liat, Ganzel, Chezi, Yeshurun, Moshe, Levi, Itay, Raanani, Pia, Akria, Luiza, Ofran, Yishai, Shimony, Shai, Wolach, Ofir

Volltext

Post-Treatment FDG-Avid Splenic Lesions in DLBCL: Clinical and Radiographic Characteristics for Risk Assessment von Nachmias, Boaz, Godefroy, Geremy, Ganzel, Chezi, Goldschmidt, Neta, Rozenbach, Eyal, Bar-Shalom, Rachel, Libster, Diana, Vainstein, Vladimir

Volltext

Recombinant interleukin‐12, but not granulocyte‐colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: Evidence fo... von Gluzman‐Poltorak, Zoya, Vainstein, Vladimir, Basile, Lena A.

Volltext